Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
94,401,153
-
Total 13F shares
-
20,679,487
-
Share change
-
+3,151,453
-
Total reported value
-
$303,862,789
-
Price per share
-
$14.70
-
Number of holders
-
55
-
Value change
-
+$45,411,611
-
Number of buys
-
19
-
Number of sells
-
28
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) as of Q1 2020
As of 31 Mar 2020,
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,679,487 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, and JANUS HENDERSON GROUP PLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.